Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

SHE:301263 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 24, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	14,675	6,348	6,948	7,683	-	-
Market Cap Growth	46.80%	-8.63%	-9.56%	-	-	-
Enterprise Value	14,397	6,066	6,271	6,685	-	-
Last Close Price	34.65	14.88	15.88	17.24	-	-
PE Ratio	156.37	58.66	43.37	44.00	-	-
Forward PE	57.75	25.85	22.52	-	-	-
PS Ratio	20.48	8.81	9.13	9.81	-	-
PB Ratio	7.95	3.50	3.80	4.14	-	-
P/TBV Ratio	10.47	4.56	4.86	4.36	-	-
P/FCF Ratio	-	305.50	-	130.35	-	-
P/OCF Ratio	175.74	71.07	74.29	51.63	-	-
EV/Sales Ratio	20.09	8.41	8.24	8.53	-	-
EV/EBITDA Ratio	149.56	37.34	28.37	29.48	-	-
EV/EBIT Ratio	152.07	55.12	34.14	34.32	-	-
EV/FCF Ratio	-2549.28	291.91	-	113.43	-	-
Debt / Equity Ratio	0.17	0.13	0.10	0.01	0.15	0.21
Debt / EBITDA Ratio	3.34	1.48	0.79	0.10	0.70	0.59
Debt / FCF Ratio	-	11.68	-	0.39	1.45	3.90
Asset Turnover	0.31	0.32	0.36	0.53	0.74	0.94
Inventory Turnover	2.80	3.33	3.64	4.18	3.70	3.33
Quick Ratio	2.39	2.68	4.21	9.15	2.23	1.64
Current Ratio	2.76	3.05	4.69	9.81	2.66	2.20
Return on Equity (ROE)	4.59%	5.32%	8.33%	13.62%	18.47%	28.25%
Return on Assets (ROA)	2.53%	3.03%	5.38%	8.17%	8.98%	15.85%
Return on Capital (ROIC)	2.78%	3.38%	5.91%	9.03%	10.38%	18.59%
Return on Capital Employed (ROCE)	4.80%	5.70%	9.30%	10.30%	17.30%	31.00%
Earnings Yield	0.64%	1.70%	2.31%	2.27%	-	-
FCF Yield	-0.04%	0.33%	-1.53%	0.77%	-	-
Dividend Yield	0.56%	1.34%	1.89%	2.26%	-	-
Payout Ratio	144.11%	124.86%	104.11%	49.14%	3.56%	42.37%
Buyback Yield / Dilution	-2.15%	1.27%	-6.23%	-24.87%	-6.49%	-5.67%
Total Shareholder Return	-1.56%	2.61%	-4.34%	-22.62%	-6.49%	-5.67%

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.